Recombinant Human XCL1 Protein，His

XCL1, or X-C motif chemokine ligand 1, is a cytokine belonging to the CC chemokine family, playing a critical role in immune responses by attracting T cells and dendritic cells to sites of inflammation. Its significance has garnered attention in various fields of biomedical research, particularly in cancer immunology and autoimmune diseases. Recent studies have highlighted the potential of XCL1 as a therapeutic target due to its involvement in tumor microenvironments and its ability to modulate immune responses. Researchers have focused on the production and characterization of recombinant XCL1 protein to better understand its biological functions and mechanisms. This recombinant protein facilitates in vitro studies, allowing for the examination of XCL1's interactions with its receptor, XCR1, and its effects on immune cell recruitment and activation. Furthermore, understanding the structure-function relationship of XCL1 through recombinant variants could lead to novel therapies enhancing anti-tumor immunity or alleviating autoimmune disorders. Given the increasing evidence of XCL1's critical role in shaping immune responses, ongoing research aims to elucidate its potential as a biomarker for disease prognosis and treatment response, showcasing the importance of XCL1 recombinant protein in advancing therapeutic strategies in immuno-oncology.